AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2017
Apr 10, 2017
29745_dirs_2017-04-10_d20208fe-8f2d-40e0-a9b6-27d802db44b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-04-03
Reporting Person: Shaw Christi (SVP and Pres., Lilly Bio-Meds)
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29